A Multicenter Randomized Controlled Trial: The Efficacy of Suvorexant in Prevention of Postoperative Delirium after Cardiac Surgery
Latest Information Update: 30 Jan 2020
Price :
$35 *
At a glance
- Drugs Suvorexant (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 09 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 30 May 2018 Status changed from not yet recruiting to recruiting.
- 16 May 2017 New trial record